Chemoenzymatic synthesis of a cholesterol-g-poly(amine-co-ester) carrier for p53 gene delivery to inhibit the proliferation and migration of tumor cells. (19th July 2018)

• Record Type: Journal Article
• Authors: Dong, Mengmeng; Chen, Jiawen; Yang, Jiebing; Jiang, Wei; Han, Haobo; Li, Quanshun; Yang, Yan
• Is Part Of: New journal of chemistry. Volume 42:Number 16(2018)
• Page Start: 13541
• Page End: 13548
• Publication Date: 2018-07-19
• Subjects: Chemistry -- Periodicals; Chimie -- Périodiques; 540
• DOI: 10.1039/c8nj02574f
• Languages: English
• ISSNs: 1144-0546

Abstract

Abstract : An amphiphilic cholesterol- g -poly(amine- co -ester) synthesized via a chemoenzymatic route has been successfully applied as a carrier in p53 gene delivery. Abstract : An amphiphilic cholesterol- g -poly(amine- co -ester) synthesized via a chemoenzymatic route has been successfully applied as a carrier in p53 gene delivery. The carrier was shown to possess favorable plasmid binding and condensation ability with a hydrodynamic size and a zeta potential of 89.1 ± 1.8 nm and +9.1 ± 1.8 mV, respectively, at a mass ratio of 40. Using the human cervical carcinoma cell line HeLa as a model, carrier/p53 transfection has been demonstrated to improve the expression level of the p53 gene by qPCR and western blotting. After the successful p53 gene delivery, an obvious anti-proliferative effect was observed by the MTT method, Live/Dead staining and colony formation inhibition assays. The inhibition mechanism of cell proliferation was further shown to be associated with the induction of cell cycle arrest at the S phase and cell apoptosis through the activation of the mitochondria-dependent signaling pathway. Finally, the migration of tumor cells was restrained after p53 transfection, as elucidated by wound healing and Transwell migration assays. In summary, cholesterol- g -poly(amine- co -ester)-mediated p53 gene transfection could be a potential route to achieve p53-based gene therapy.